login
login

Europe Daily Bulletin No. 7812

4 October 2000
Contents Publication in full By article 27 / 50
ECONOMIC INTERPENETRATION / (eu) medical material

The French EDAP TECHNOMED (turnover of FF 150 million forecasted for 2000) sold its "Prostatron" activity (benign prostrate tumour treatment) to the American UROLOGIX for USD 20 million.

Contents

THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION